Corcept Therapeutics Q1 Loss Widens

(RTTNews) - Corcept Therapeutics Incorporated (CORT) Wednesday reported first-quarter net loss of $13.9 million or $0.14 per share, wider than $12.1 million or $0.12 per share in the comparable quarter last year.

Adjusted loss for the quarter widened to $11.5 million or $0.11 per share from $9.7 million or $0.10 per share in the prior year period.

On average, four analysts polled by Thomson Reuters expected the company to report a loss of $0.09 per share for the quarter. Analysts' estimates typically exclude special items.

Sales increased to $4.41 million from $1.72 million last year, while four analysts expected sales of $5.01 million.